… , early low-dose hydrocortisone therapy was shown to confer … )4 without adverse
neurodevelopmental outcomes at 2 years … factors for adverse neurodevelopmental outcomes …

… and the duration of hydrocortisone still remain undetermined; … duration of hydrocortisone on
neurodevelopmental outcomes. … start day of hydrocortisone therapy was day 15.6; however, …

… difference in the composite primary outcome of death or bronchopulmonary dysplasia at 36
… hydrocortisone. We examined the prespecified follow-up of death and neurodevelopmental …

… The majority (1184) had received early therapy for hypotension. There were 11 infants for …
severe neurodevelopmental impairment and other growth and neurodevelopmental outcomes …

… Early or late hydrocortisone hemisuccinate has been … to post-natal DXM on neurodevelopment
outcomes at 24 months … between antibiotic therapy and neurodevelopment is slightly …

… Conclusion: Early systemic hydrocortisone is a modestly effective therapy for the prevention
… However, we have only been able to analyse neurodevelopmental outcomes up to 2 years …

… on mortality or neurodevelopmental outcomes. There was no … While systemic hydrocortisone
therapy is becoming more … using low-dose hydrocortisone resulted in improved survival …

… Although this number is certainly too small to evaluate any effect of hydrocortisone therapy,
we herein briefly summarize their outcomes at age 2. None of the infants died. Three in each …

… hydrocortisone group. These results are consistent with the previously reported
neurodevelopmental outcomes at 2 years’ CA of the SToP-BPD study, assessed with the …

… None of them reported deleterious effects of hydrocortisone treatment on neurodevelopmental
outcomes at 2 years of age. The lack of detectable side effects on brain development …